Dianthus Therapeutics (DNTH) cash on hand

Cash · fiscal 2025
$404.30M

Dianthus Therapeutics (DNTH) held cash of $404.30M at the end of fiscal 2025 (December 31, 2025). That is 46.9% higher than the $275.24M of fiscal 2024. Figures as of 17 Nov 2026, 23:34 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Cash, fiscal 2025
$404.30M
Change on fiscal 2024
+46.9%
Highest on record
$404.30Mfiscal 2025
Lowest on record
$75.49Mfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Dianthus Therapeutics cash on hand, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $404.30M in fiscal 2025 and the lowest $75.49M in fiscal 2022.

History · 4 fiscal years

Cash by fiscal year

Dianthus Therapeutics cash on hand, year by year

Dianthus Therapeutics (DNTH) cash on hand by fiscal year
Fiscal yearCashChangeYear ended
2025$404.30M 46.9% up
2024$275.24M 58.4% up
2023$173.72M 130.1% up
2022$75.49M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

How to read it

Cash is the cushion that pays for bad years, buybacks and acquisitions; compare it with total debt to see whether the company is a net borrower.

Cash at health care companies of similar size

Cash of Dianthus Therapeutics and comparable companies
CompanyCashFiscal year
LivaNova LIVN$635.55M2025
Ionis Pharmaceuticals IONS$2.68B2025
Dianthus Therapeutics DNTH$404.30M2025
MiniMed Group MMED$298.00M2026
Adaptive Biotechnologies ADPT$226.98M2025
Heartflow HTFL$176.79M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on DNTH

Dianthus Therapeutics, figure by figure

Dianthus Therapeutics (DNTH) overview: price, valuation and scorecardAll health care companies by market value

Dianthus Therapeutics cash on hand: questions and answers

How much cash does Dianthus Therapeutics have?

Dianthus Therapeutics (DNTH) held cash of $404.30M at the end of fiscal 2025 (December 31, 2025). That is 46.9% higher than the $275.24M of fiscal 2024.

What are the highest and lowest cash figures on record for Dianthus Therapeutics?

Across the 4 fiscal years on record (2022–2025), the highest was $404.30M in fiscal 2025 and the lowest $75.49M in fiscal 2022.

How is Dianthus Therapeutics's cash calculated?

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Dianthus Therapeutics (DNTH) cash on hand”, data as of 17 November 2026. https://funkfolio.com/stock/DNTH/cash

Underlying data: the company's filings with the SEC and Yahoo Finance.